Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3700 3762 3769 3771 3792 3796
This examiner grants 76% of resolved cases
Sebastian X. Lukjan operates in Art Unit 3700 within Tech Center 3700. Across 532 resolved cases, the examiner has an allowance rate of 76.3 percent. This figure indicates a favorable environment for patent grants, with more than three-quarters of cases reaching a successful conclusion. Practitioners can use the 76.3 percent rate to provide clients with a positive outlook on the likelihood of success.
The interview lift is 40.3 percent. This high lift suggests that interviews are a critical tool for overcoming rejections and securing an allowance. Practitioners should prioritize direct communication, as the 40.3 percent lift significantly improves the odds of a grant compared to cases without an interview. This metric highlights the substantial impact that verbal engagement has on the prosecution process with this examiner.
The median days to allowance is 1102. This duration represents the typical time required for successful prosecution, lasting about three years. The 76.3 percent allowance rate and 1102-day median offer a predictable path for applications. These data points allow practitioners to plan their timelines and emphasize the importance of interviews in achieving a successful result within this timeframe.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18751907 | TENSIONING MECHANISMS AND METHODS FOR ARTICULATING SURGICAL INSTRUMENTS SUCH AS FOR USE IN ROBOTIC SURGICAL SYSTEMS | Final Rejection | Covidien LP |
| 17830878 | INTRODUCER LOCK APPARATUS | Final Rejection | Boston Scientific Scimed, Inc. |
| 18885624 | ECG-BASED CARDIAC EJECTION-FRACTION SCREENING | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18819710 | SYSTEM AND METHODS FOR AUTOMATED DEEP BRAIN STIMULATION PARAMETER SELECTION VIA META-ACTIVE LEARNING OF EVOKED POTENTIALS | Final Rejection | Emory University |
| 18691824 | DEHYDRATION ESTIMATION DEVICE, ESTIMATION METHOD AND PROGRAM | Final Rejection | NTT, Inc. |
| 17937675 | VITREORETINAL VISUALIZATION FOR OPHTHALMIC PROCEDURES | Final Rejection | Alcon Inc. |
| 18891386 | SYSTEMS AND METHOD FOR IMPROVED SURGICAL OR GRAFT ACCESS | Non-Final OA | ABIOMED, Inc. |
| 18200207 | ENDOSCOPE CAP, LIGHT TREATMENT ENDOSCOPE SYSTEM, AND LIGHT TREATMENT METHOD | Final Rejection | OLYMPUS CORPORATION |
| 18688210 | ELECTRIC FIELD THERAPY VIA IMPLANTABLE ELECTRODE | Final Rejection | Medtronic, Inc |
| 17127227 | AUTOMATIC POST PACING INTERVAL MEASUREMENT AND DISPLAY | Final Rejection | Biosense Webster (Israel) Ltd. |
| 19245147 | Fixation Target for Macula Protection | Final Rejection | NeuroRays, LLC |
| 18919208 | SURGICAL OPERATING SYSTEM, SURGICAL TOOL AND METHOD FOR SAFEGUARDING A SURGICAL OPERATION | Non-Final OA | CARL ZEISS MEDITEC AG |
| 18858490 | SYSTEMS AND METHODS FOR CLOSED LOOP NEUROMODULATION | Non-Final OA | NERVONIK INC. |
| 17789735 | CONDUCTIVE THERMOPLASTIC ELASTOMER ELECTRODES, AND METHOD OF MANUFACTURING SUCH ELECTRODES | Final Rejection | MGI HOLDCO LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy